FDA — authorised 14 October 2020
- Marketing authorisation holder: REGENERON PHARMACEUTICALS
- Status: approved
🇺🇸 Inmazeb in United States
FDA authorised Inmazeb on 14 October 2020
Marketing authorisations
FDA — authorised 14 October 2020
- Application: BLA761169
- Marketing authorisation holder: REGENERON PHARMACEUTICALS
- Local brand name: INMAZEB
- Indication: SOLUTION — INJECTION
- Status: approved
Inmazeb in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Inmazeb approved in United States?
Yes. FDA authorised it on 14 October 2020; FDA authorised it on 14 October 2020.
Who is the marketing authorisation holder for Inmazeb in United States?
REGENERON PHARMACEUTICALS holds the US marketing authorisation.